Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12594348 | Compositions for treating Friedreich's ataxia | 🖼🧊📄§ | 2026-04-07 | 2040-12-18 | 0 | 31 |
| 12594351 | Methods for increasing shelf-life of ophthalmic pharmaceutical compositions | 🖼🧊📄§ | 2026-04-07 | 2042-08-04 | 0 | 31 |
| 12594345 | Degradable hyaluronic acid hydrogels | 🖼🧊📄§ | 2026-04-07 | 2039-09-25 | 0 | 31 |
| 12594349 | Compositions and methods for the targeting of PCSK9 | 🖼🧊📄§ | 2026-04-07 | 2043-11-21 | 0 | 31 |
| 12594047 | Contrast agent-based vascular imaging | 🖼🧊📄§ | 2026-04-07 | 2040-11-04 | 0 | 31 |
| 12594184 | Packaged lubricated condom | 🖼🧊📄§ | 2026-04-07 | 2042-02-10 | 0 | 31 |
| 12593863 | Probiotics to prevent cognitive dysfunction | 🖼🧊📄§ | 2026-04-07 | 2041-10-08 | 0 | 31 |
| 12590134 | GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof | 🖼🧊📄§ | 2026-03-31 | 2042-08-17 | 0 | 31 |
| 12590129 | Liver-specific regulatory nucleic acid sequences | 🖼🧊📄§ | 2026-03-31 | 2039-11-19 | 0 | 31 |
| 12590153 | Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and an anti-CTLA-4 antibody | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12589147 | Multivalent HVT vector vaccine | 🖼🧊📄§ | 2026-03-31 | 2040-12-18 | 0 | 31 |
| 12589070 | Low-dosage orodispersible opioid tablet and method for preparing same | 🖼🧊📄§ | 2026-03-31 | 2040-08-13 | 0 | 31 |
| 12589153 | Polyurethane excipient | 🖼🧊📄§ | 2026-03-31 | 2044-12-17 | 0 | 31 |
| 12589148 | Immunity-inducing agent comprising antigen peptide-adjuvant nucleotide conjugate and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-03-31 | 2039-09-27 | 0 | 31 |
| 12589189 | Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve | 🖼🧊📄§ | 2026-03-31 | 2040-10-01 | 0 | 31 |
| 12589145 | Systems to produce B cells genetically modified to express selected antibodies | 🖼🧊📄§ | 2026-03-31 | 2043-02-08 | 0 | 31 |
| 12589168 | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems | 🖼🧊📄§ | 2026-03-31 | 2042-04-29 | 0 | 31 |
| 12589077 | Method for preparing biodegradable microcapsules and microcapsules thus obtained | 🖼🧊📄§ | 2026-03-31 | 2041-11-18 | 0 | 31 |
| 12589135 | Topical administration of GLP-1 receptor agonists | 🖼🧊📄§ | 2026-03-31 | 2043-08-21 | 0 | 31 |
| 12589110 | Carbonated aerosol external preparation for skin | 🖼🧊📄§ | 2026-03-31 | 2041-10-01 | 0 | 31 |
| 12589134 | Compositions and methods of use of interleukin-10 in combination with immune check-point pathway inhibitors | 🖼🧊📄§ | 2026-03-31 | 2043-10-17 | 0 | 31 |
| 12589139 | Clostridial neurotoxins comprising an exogenous activation loop | 🖼🧊📄§ | 2026-03-31 | 2039-09-27 | 0 | 31 |
| 12590188 | Tri-block copolymers and nano-fibrous gelling microspheres including the same | 🖼🧊📄§ | 2026-03-31 | 2040-04-09 | 0 | 31 |
| 12589136 | Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies | 🖼🧊📄§ | 2026-03-31 | 2042-08-09 | 0 | 31 |
| 12589374 | Method for making multiparticulates from a liquid feed employing a spinning disc sprayer | 🖼🧊📄§ | 2026-03-31 | 2041-06-15 | 0 | 31 |
| 12590286 | Method for preparing agent for prevention of hair loss and promotion of hair regrowth through fusion fermentation of lactic acid bacteria | 🖼🧊📄§ | 2026-03-31 | 2043-06-21 | 0 | 31 |
| 12590266 | Free polyunsaturated fatty acid-containing compositions and manufacturing method therefor | 🖼🧊📄§ | 2026-03-31 | 2044-04-15 | 0 | 31 |
| 12590010 | Titanium oxide powder and method for manufacturing same | 🖼🧊📄§ | 2026-03-31 | 2040-05-13 | 0 | 31 |
| 12590331 | Methods of determining whether a subject has or is at risk of having a central serous chorioretinopathy | 🖼🧊📄§ | 2026-03-31 | 2041-03-10 | 0 | 31 |
| 12590292 | Targeted T-cell therapy for treatment of multiple myeloma | 🖼🧊📄§ | 2026-03-31 | 2040-01-07 | 0 | 31 |
| 12590304 | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | 🖼🧊📄§ | 2026-03-31 | 2040-05-21 | 0 | 31 |
| 12590335 | Targeted measure of transcriptional activity related to hormone receptors | 🖼🧊📄§ | 2026-03-31 | 2043-06-21 | 0 | 31 |
| 12590308 | Compositions and methods for suppressing intracellular synthesis of the beta subunit of human chorionic gonadotropin | 🖼🧊📄§ | 2026-03-31 | 2045-02-20 | 0 | 31 |
| 12590288 | Method of treating an inflammatory disease by administering an agent which binds a surface receptor on a tuft cell that induces an ILC class 2 inflammatory response | 🖼🧊📄§ | 2026-03-31 | 2038-04-12 | 0 | 31 |
| 12590950 | Methods for predicting ER-mediated DNA damage | 🖼🧊📄§ | 2026-03-31 | 2040-10-12 | 0 | 31 |
| 12590309 | Reprogramming of lipid metabolism to inhibit T cell senescence and enhance tumor immunotherapy | 🖼🧊📄§ | 2026-03-31 | 2040-05-19 | 0 | 31 |
| 12589184 | Clinical dressing loaded with coffee extract | 🖼🧊📄§ | 2026-03-31 | 2045-06-18 | 0 | 31 |
| 12589125 | Yogurt for regulating intestinal tract, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-03-31 | 2043-02-27 | 0 | 31 |
| 12590168 | Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2044-01-23 | 0 | 31 |
| 12590123 | Compounds and methods for treating cancer, viral infections, and allergic conditions | 🖼🧊📄§ | 2026-03-31 | 2040-06-25 | 0 | 31 |
| 12590139 | MHC class II molecules and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-07-29 | 0 | 31 |
| 12590157 | Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments | 🖼🧊📄§ | 2026-03-31 | 2043-07-20 | 0 | 31 |
| 12589133 | Methods of downregulating CCL20 genes for treatment of traumatic brain injuries | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12590149 | Antibody and bispecific antibody targeting LAG-3 and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-06-11 | 0 | 31 |
| 12589122 | Methods and compositions for treating infectious, autoimmune, and allergic disease | 🖼🧊📄§ | 2026-03-31 | 2039-11-05 | 0 | 31 |
| 12589092 | Polycyclic compound acting as kinase inhibitor | 🖼🧊📄§ | 2026-03-31 | 2041-01-11 | 0 | 31 |
| 12589121 | Method for obtaining occlusive biological dressing, occlusive biological dressing, use thereof and kit | 🖼🧊📄§ | 2026-03-31 | 2039-11-14 | 0 | 31 |
| 12589115 | Haematopoietic stem cell treatment | 🖼🧊📄§ | 2026-03-31 | 2039-03-29 | 0 | 31 |
| 12589085 | Use of diaminoguanidine derivative and feed composition thereof in preparation of veterinary drug | 🖼🧊📄§ | 2026-03-31 | 2039-07-22 | 0 | 31 |
| 12589094 | Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4 | 🖼🧊📄§ | 2026-03-31 | 2044-02-28 | 0 | 31 |